prednisone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 249 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we analysed whether treatment with cladribine (2-chlorodeoxyadenosine, 2-CdA) during the course of CLL had an impact on the subsequent occurrence of either secondary solid tumours or Richter's syndrome." | 7.72 | Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. ( Blonski, JZ; Całbecka, M; Ceglarek, B; Dmoszyńska, A; Dwilewicz-Trojaczek, A; Gora-Tybor, J; Hellmann, A; Kasznicki, M; Komarnicki, M; Konopka, L; Lewandowski, K; Moskwa, A; Robak, T; Sokołowska, B; Sułek, K; Tomaszewska, A, 2004) |
| "The aim of the study was to determine the effectiveness and toxicity of cladribine (2-CdA) used alone or in combination with prednisone (P) or cyclophosphamide and mitoxantrone in re-treatment of patients with progressive B-cell chronic lymphocytic leukemia (B-CLL)." | 7.71 | Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment. ( Boński, JZ; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Hellmann, A; Kasznicki, M; Konopka, L; Robak, T; Wołowiec, D, 2002) |
| "Fludarabine (FAMP) is the most active single agent in relapsed and refractory patients with B-cell chronic lymphocytic leukemia (B-CLL)." | 7.71 | Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. ( Battista, C; Broccia, G; Capalbo, S; Castoldi, G; Cuneo, A; Leoni, P; Liso, V; Molica, S; Montillo, M; Pogliani, E; Specchia, G, 2001) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 5.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| " He had a history of chronic lymphocytic leukemia with transformation to diffuse large B-cell lymphoma for which he was started on dose-adjusted rituximab, etoposide, prednisone vincristine, cyclophosphamide, and doxorubicin (DA-R-EPOCH)." | 4.02 | Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report. ( Abou-Ghanem, N; Agab, M; Egoryan, G; Filipiuk, D; Gidron, A; Ibrahim, R; Murguia-Fuentes, R; Pyakuryal, B; Rodriguez-Nava, G; Trelles-Garcia, DP; Yanez-Bello, MA, 2021) |
| " A 52 year old woman is reported who was on long term treatment with chlorambucil and taking a short course of prednisone for familial CLL before she developed progressive dyspnoea, and P carinii pneumonia was diagnosed in bronchoalveolar lavage fluid." | 3.72 | Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. ( Halter, J; Hechelhammer, L; Himmelmann, A; Vavricka, SR, 2004) |
| " In this study, we analysed whether treatment with cladribine (2-chlorodeoxyadenosine, 2-CdA) during the course of CLL had an impact on the subsequent occurrence of either secondary solid tumours or Richter's syndrome." | 3.72 | Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. ( Blonski, JZ; Całbecka, M; Ceglarek, B; Dmoszyńska, A; Dwilewicz-Trojaczek, A; Gora-Tybor, J; Hellmann, A; Kasznicki, M; Komarnicki, M; Konopka, L; Lewandowski, K; Moskwa, A; Robak, T; Sokołowska, B; Sułek, K; Tomaszewska, A, 2004) |
| "Fludarabine (FAMP) is the most active single agent in relapsed and refractory patients with B-cell chronic lymphocytic leukemia (B-CLL)." | 3.71 | Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. ( Battista, C; Broccia, G; Capalbo, S; Castoldi, G; Cuneo, A; Leoni, P; Liso, V; Molica, S; Montillo, M; Pogliani, E; Specchia, G, 2001) |
| "The aim of the study was to determine the effectiveness and toxicity of cladribine (2-CdA) used alone or in combination with prednisone (P) or cyclophosphamide and mitoxantrone in re-treatment of patients with progressive B-cell chronic lymphocytic leukemia (B-CLL)." | 3.71 | Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment. ( Boński, JZ; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Góra-Tybor, J; Hellmann, A; Kasznicki, M; Konopka, L; Robak, T; Wołowiec, D, 2002) |
| "The MiNa protocol (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone) was given to 20 patients with advanced B-cell chronic lymphocytic leukemia." | 3.67 | A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol). ( Del Vecchio, L; Ferrara, F; Mele, G; Montuori, R; Rametta, V; Ronconi, F, 1989) |
| "Richter syndrome (RS) of chronic lymphocytic leukemia (CLL) is typically chemoresistant, with a poor prognosis." | 3.11 | Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome. ( Brown, JR; Davids, MS; Fisher, DC; Ihuoma, U; Jacobson, CA; Lehmberg, TZ; Montegaard, J; Parry, EM; Pazienza, S; Renner, SK; Rogers, KA; Thompson, PA; Tyekucheva, S; Wang, Z; Wu, CJ, 2022) |
| "The transformation of chronic lymphocytic leukemia (CLL) to high-grade B-cell lymphoma is known as Richter syndrome (RS), a rare event with dismal prognosis." | 3.01 | Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia. ( Appleby, N; Cabes, M; Campo, E; Dreau, H; Ehinger, M; Eyre, TA; Klintman, J; Knight, SJL; Månsson, R; Martín-Subero, JI; Pascua, LL; Popitsch, N; Ridout, K; Robbe, P; Rossi, D; Schuh, A; Stamatopoulos, B; Taylor, JC; Vavoulis, DV, 2021) |
| "application of rituximab combined with fludarabine and cyclophosphamide in the treatment of CLL shows the higher curative effect, can effectively improve the symptoms and reduce the incidence of adverse reactions." | 2.82 | [Clinical Efficacy and Safety of Rituximab Combined with Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia]. ( Han, HJ; Lu, YW; Xia, RX, 2016) |
| "The CHOP-OR study is a prospective phase II study to evaluate the safety, feasibility and activity of a CHOP chemotherapy in combination with ofatumumab in induction and subsequent maintenance for patients with newly diagnosed RS." | 2.80 | Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome. ( Boyle, L; Clifford, R; Dutton, SJ; Eyre, TA; Francis, A; Roberts, C; Schuh, A, 2015) |
| "Of 79 evaluable patients, 58 (73%) had follicular lymphoma, 13 (16%) mantle cell lymphoma and 8 (10%) lymphoplasmacytic lymphoma." | 2.73 | Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. ( Dörken, B; Dreyling, M; Forstpointner, R; Freund, M; Ganser, A; Hiddemann, W; Hoster, E; Huber, C; Ludwig, WD; Nickenig, C; Trümper, L; Unterhalt, M, 2007) |
| "Myelosuppression and infections were dose limiting whereas posttreatment complications, including fatalities, resulted from infections." | 2.73 | The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. ( Ballabeni, P; Cerny, T; Fey, M; Hess, U; Laurencet, F; Luthi, JM; Plancherel, C; Rufener, B; Zulian, GB, 2007) |
| "A total of 164 patients with follicular lymphoma (grade 1/2), mantle cell lymphoma or lymphoplasmacytic lymphoma (immunocytoma) was randomised to treatment with vincristine 2 mg (day 1) and prednisone 100 mg/m2 (days 1-5) + bendamustine 60 mg/m2 (days 1-5) or + cyclophosphamide 400 mg/m2 (days 1-5) for a total of eight 21-day cycles." | 2.72 | Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19). ( Arzberger, H; Boewer, C; Bremer, K; Dachselt, K; Franke, A; Freund, M; Fricke, HJ; Hahnfeld, S; Herold, M; Ismer, B; Klinkenstein, C; Müller, C; Niederwieser, D; Pasold, R; Richter, P; Schirmer, V; Schulze, A; Schulze, M; Schwarzer, A; Weniger, J; Winkelmann, C, 2006) |
| "Pentostatin was evaluated in combination with orally administered chlorambucil 30 mg/m2 and prednisone 80 mg/day, 1-5 of each 14-day cycle." | 2.71 | Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488. ( Cassileth, PA; Kay, NE; Knospe, W; Lee, S; Oken, MM, 2004) |
| "Although chlorambucil slowed disease progression, there was no effect on overall survival." | 2.69 | Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. ( Binet, JL; Cazin, B; Desablens, B; Dighiero, G; Dreyfus, B; Jaubert, J; Leblay, R; Lepeu, G; Leporrier, M; Maloum, K; Navarro, M; Travade, P, 1998) |
| "Infections were seen more frequently in the 2-CdA+P-treated group (56%) than in the Chl+P-treated group (40%; P = ." | 2.69 | Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. ( Blasińska-Morawiec, M; Bloński, JZ; Ceglarek, B; Dmoszyńska, A; Dwilewicz-Trojaczek, J; Grieb, P; Hellmann, A; Kasznicki, M; Konopka, L; Kotlarek-Haus, S; Krykowski, E; Maj, S; Mrugala-Spiewak, H; Nowak, W; Potoczek, S; Robak, T; Skotnicki, AB; Urasiński, I; Zdziarska, B, 2000) |
| "Patients with advanced, refractory chronic lymphocytic leukemia (CLL) have an high morbidity and mortality from infections following chemotherapy-induced myelosuppression." | 2.68 | Effect of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) on chemotherapy-induced myelosuppression in patients with chronic lymphocytic leukemia: a crossover study. ( Itälä, M; Remes, K; Vanhatalo, S, 1997) |
| " All patients needed course shortening and dosage reduction." | 2.68 | Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia. ( Bairey, O; Blickstein, D; Hadar, H; Lahav, M; Prokocimer, M; Shaklai, M; Shaklai, S; Sulkes, J, 1996) |
| "Two hundred sixty-four patients with chronic lymphocytic leukemia were treated with fludarabine 30 mg/m2 intravenously for 30 minutes each day for 5 days and with prednisone 30 mg/m2 orally each day for 5 days." | 2.67 | Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. ( Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, C; Lerner, S; O'Brien, S; Robertson, LE; Smith, T, 1993) |
| "Diffuse intermediately differentiated lymphocytic lymphoma (IDL) is a rare (approximately 2." | 2.67 | Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors. ( Bookman, MA; Duffey, PL; Jaffe, ES; Lardelli, P; Longo, DL, 1990) |
| "In 1985, the French Cooperative Group on Chronic Lymphocytic Leukemia started a protocol based on the (A, B, C) staging system." | 2.66 | CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia. ( , 1988) |
| "was diagnosed with chronic lymphocytic leukemia (CLL)." | 2.52 | Richter syndrome: an aggressive transformation. ( Streu, E, 2015) |
| " This review summarizes its efficacy and toxicity, and focuses on the pharmacokinetic features of vincristine that affect clinical outcomes." | 2.50 | Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies. ( Said, R; Tsimberidou, AM, 2014) |
| "We report a 77-year-old female with chronic lymphocytic leukemia and granulomatous vasculitis, which highlights the features of this association, and expands the clinical data." | 2.48 | Cutaneous granulomatous vasculitis associated with chronic lymphocytic leukemia: case report and review of literature of a rare entity. ( Gaertner, EM; Switlyk, SA, 2012) |
| "We report chronic lymphocytic leukemia-associated PNP in a patient who presented with extensive and debilitating painful oral ulcerations and received ablative therapy." | 2.40 | Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. ( Anhalt, GJ; Brodsky, RA; Grever, MR; Jones, RJ; Nousari, HC, 1999) |
| "Although hypercalcemia is more frequently found in T-cell leukaemia associated with human T lymphotropic lymphocyte type I, scattered reports indicate that patients with B-CLL can also be affected with this metabolic disturbance." | 2.39 | B-CLL in PLL transformation associated with hypercalcemia. ( De Oliveira, MS; Esteves, C; Lerner, D, 1994) |
| "Not all patients with B-cell chronic lymphocytic leukemia require therapy." | 2.38 | A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities. ( Phyliky, RL; Tefferi, A, 1992) |
| " The onset of symptoms may occur after only some weeks or after up to several years with no dose-response relationship." | 2.38 | Interstitial lung disease--an underdiagnosed side effect of chlorambucil? ( Huhn, D; Kingreen, D; Mohr, M; Rühl, H, 1993) |
| "(fludarabine phosphate) is a purine analogue that has been synthesized and found to have activity in lymphoid neoplasms in phase I and II studies." | 2.38 | Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. ( Keating, MJ, 1990) |
| "Two patients developed non-Hodgkin's lymphoma (NHL) six and ten years after radiotherapy and chemotherapy for Hodgkin's disease nodular sclerosis type." | 2.37 | Non Hodgkin's lymphomas following chemoradiotherapy for Hodgkin's disease. Two new cases and a review of the literature. ( Cuesta, B; Gómez-Bezares, MC; Idoate, MA; Marigil, MA; Pardo-Mindan, FJ; Rocha, E, 1986) |
| "We report a patient with chronic lymphocytic leukemia who presented with a large and rapidly evolving ulcer, revealed to be a high-grade cutaneous lymphoma." | 1.56 | Ulcerated cutaneous Richter syndrome. ( De Mello, RB; Do Vale, ECS, 2020) |
| "BACKGROUND Most patients with chronic lymphocytic leukemia (CLL) are asymptomatic at diagnosis, but 10% present with B symptoms." | 1.56 | Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic Leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge. ( Abdulla, MAJ; Aldapt, MB; Sharaf Eldean, MZ; Shwaylia, HM; Soliman, D; Szabados, L; Yassin, MA, 2020) |
| "BACKGROUND Tumor lysis syndrome is common in hematological malignancy, but less frequent in chronic and solid tumors." | 1.51 | Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: A Rare Case Report from Nephrology. ( Armaly, Z; Artoul, S; Elias, M; Hamzeh, M; Jabbour, AR; Saffouri, A; Yasin, R, 2019) |
| "Chronic lymphocytic leukemia is one of the main causes of hematological malignancies associated." | 1.46 | Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies. ( Bastida, JM; Cano-Mozo, MT; Carrillo, J; González, M; González-Calle, D; González-Porras, JR; Lopez-Cadenas, F; Martín, AA; Martín-Herrero, F; Merchán, S; Pabón, P; Santos-Montón, C; Torres-Hernández, JA; Vallejo, VE, 2017) |
| "Interestingly, in chronic lymphocytic leukemia (CLL) patients, we found that the patients with β2-microglobulin (β2-MG) < 3." | 1.42 | Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China. ( Feng, X; Gu, Z; Li, F; Li, Z; Liu, W; Qi, J; Qiu, L; Xu, Y; Yi, S; Yu, Z; Zhan, F; Zou, D, 2015) |
| "Chlorambucil was used in only 7% (first-line) and 6% (second-line) of patients." | 1.42 | Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms. ( Abenhardt, W; Dörfel, S; Grugel, R; Hartmann, H; Knauf, W; Marschner, N; Meyer, D; Münz, M, 2015) |
| "Patients with chronic lymphocytic leukemia or non-Hodgkin’s lymphoma are at risk of infectious diseases of respiratory system because of immunodeficiency." | 1.42 | Organizing pneumonia appearing in B-cell chronic leukemia malignancy progression - a case report. ( Maksymiuk, B; Opoka, L; Polaczek, MM; Roszkowski-Sliż, K; Zych, J, 2015) |
| "The median age at diagnosis of chronic lymphocytic leukemia (CLL) is 72, but patients enrolled in randomized trials are often a decade younger." | 1.40 | Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database. ( Hoang, KQ; Momin, F; Reyes, C; Satram-Hoang, S; Skettino, S, 2014) |
| "Waldenström macroglobulinemia is LPL." | 1.36 | [Clinicopathologic features of lymphoplasmacytic lymphoma]. ( Fang, LH; Li, ZQ; Liu, EB; Qiu, LG; Sun, FJ; Sun, Q; Yang, QY; Zhang, PH, 2010) |
| "The diagnosis was Hodgkin's disease." | 1.36 | Hodgkin's lymphoma variant of Richter's syndrome. ( Curić-Jurić, S; Kelcec, IB; Kojić-Katović, S; Maricević, I; Tomas, D; Vasilj, A; Zokvić, E, 2010) |
| "ten patients with low grade lymphomas: follicular lymphoma grades I and II, marginal zone lymphoma, and small cell lymphocytic lymphoma with progressive disease were studied." | 1.35 | Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate. ( Bertino, JR; Gharibo, M; Levitt, MJ; Rubin, A; Schaar, D; Strair, R, 2009) |
| "We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy." | 1.35 | Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. ( Kovacs, JA; Masur, H, 2009) |
| "Most cats with lymphocytic lymphoma responded to treatment with prednisone and chlorambucil, and most factors evaluated were not associated with outcome." | 1.35 | Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005). ( Erb, HN; Goldstein, RE; Kiselow, MA; McDonough, SP; Rassnick, KM; Simpson, KW; Weinkle, TK, 2008) |
| "An important biological alteration in chronic lymphocytic leukemia (CLL) is the dysregulation of immunoglobulin production, as a consequence of complex and yet incompletely understood interactions between plasma cells and the neoplastic B-cell clone." | 1.35 | Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. ( Alexandrescu, DT; Wiernik, PH, 2008) |
| "Progressive B-cell chronic lymphocytic leukemia (B-CLL) is often complicated by autoimmune hemolytic anemia (AIHA), which in some cases may be refractory to conventional therapy such as corticosteroids, rituximab and splenectomy." | 1.34 | Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). ( Celsing, F; Hansson, L; Karlsson, C; Lundin, J, 2007) |
| "Histological, we mainly notified follicular lymphoma constituted of small cells 50%, followed by mixed follicular and large cells lymphomas with respectively 27." | 1.34 | [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience]. ( Koffi, G; Kouakou, B; Ndathz, E; Ndiaye, FS; Sangare, A; Sanogo, I, 2007) |
| "84." | 1.34 | [Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases]. ( Lu, Y; Lu, ZH; Pang, XY; Sui, AH; Sun, LR, 2007) |
| "We present a case of chronic lymphocytic leukemia associated with nephrotic syndrome." | 1.32 | Membranous glomerulonephritis in chronic lymphocytic leukemia. ( Giannouli, S; Nakopoulou, L; Psimenou, E; Voulgarelis, M; Ziakas, PD, 2004) |
| "Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is characterized by an acquired immune defect that can cause autoimmune complications, including anemia and thrombocytopenia." | 1.32 | Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. ( Kyasa, MJ; Parrish, RS; Schichman, SA; Zent, CS, 2003) |
| "In B-cell chronic lymphocytic leukemia (CLL) a high Bcl-2/Bax ratio contributes to death defiance." | 1.31 | Association of a novel single nucleotide polymorphism, G(-248)A, in the 5'-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. ( Moshynska, O; Sankaran, K; Saxena, A; Sheridan, DP; Viswanathan, S, 2002) |
| "A patient with chronic lymphocytic leukemia and an undetectable plasma level of protein S (PS), associated with recurrent venous thrombosis, is described." | 1.31 | Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency. ( Antunović, P; Basara, N; Bosković, D; Miljić, P; Milosević-Jovicić, N; Rolović, Z, 2000) |
| "Treatment with clarithromycin, ethambutol and rifabutin resulted in improvement of anaemia and general health as well as in regression of lymphadenopathy and splenomegaly." | 1.31 | Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. ( Bodmer, T; Krebs, T; Lämmle, B; Zimmerli, S, 2000) |
| "Paraneoplastic pemphigus is an autoimmune disease of the skin and mucosa described in 1990." | 1.31 | [Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia]. ( Huttenberger, B; Jan, V; Joly, P; Lorette, G; Machet, MC; Martin, L; Rivollier, C; Vaillant, L, 2001) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 1.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| "Primary membranous glomerulonephritis was diagnosed and immunosuppressive therapy was started." | 1.31 | Primary cerebral lymphoma and membranous nephropathy: a still unreported association. ( Maiorano, E; Manno, C; Occhiogrosso, G; Rossini, M; Schena, FP; Strippoli, GF, 2002) |
| "Treatment with chlorambucil, started in 59 patients, was in accordance with the guidelines of the national programme for 52 of them." | 1.30 | [Chronic lymphatic leukemia. A population-based study of symptoms, findings, complications and choice of treatment]. ( Bergheim, J; Dahl, IM; Grøttum, KA; Hammerstrøm, J; Ly, B; Lødemel, B, 1998) |
| "402 patients with chronic lymphocytic leukemia not previously treated or treated with chlorambucil (with or without prednisone) who received fludarabine (30 mg/m2 of body surface area per day for 5 days) with or without prednisone at 4-week intervals." | 1.30 | Infections in patients with chronic lymphocytic leukemia treated with fludarabine. ( Anaissie, EJ; Kantarjian, H; Keating, MJ; Kontoyiannis, DP; Lerner, S; O'Brien, S; Robertson, L, 1998) |
| "We describe a patient with an atypical chronic lymphocytic leukemia (CLL) of the mixed cell type with a hypercalcemia due to parathyroid hormone-related protein production by the malignant B cells." | 1.30 | Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia. ( Aarnoudse, WH; Ermens, AA; Haak, HR; Ooms, HW; Pauwels, P; Vlasveld, LT, 1999) |
| "infusions in the treatment of B cell chronic lymphocytic leukemia (B-CLL) in patients 55 years old and younger." | 1.30 | 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger. ( Błasińska-Morawiec, M; Błoński, JZ; Robak, T; Skotnicki, AB; Urbańska-Ryś, H, 1999) |
| "The incidence of trisomy 12 and p53 deletion was studied in a group of chronic B-lymphocytic leukemia (B-CLL) patients, using fluorescence in situ hybridization (FISH)." | 1.29 | Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy. ( Cano, I; Castañeda, A; Hernández-Navarro, F; López, R; Martin-Recio, A; Martinez, J; Pérez-Piño, T; Pinilla, J; Quevedo, E; Rodriguez, A, 1996) |
| "We report a case of B-cell chronic lymphocytic leukemia in a 58 year old female in whom the clinical course was dominated by upper airway obstruction due to massive enlargement of the palatine and later the lingual tonsils." | 1.29 | Chronic lymphocytic leukaemia with upper airway obstruction. ( Cole, I; Cunningham, I; Dao, LP; Dean, MG; Mulligan S, P, 1996) |
| "Spinal cord compression has been reported in 5% of patients with solid tumors." | 1.29 | [Spinal cord compression as the presenting form of non-Hodgkin's lymphoma]. ( Amigo, ML; Caballero, D; del Cañizo, C; Revilla, R; San Miguel, JF; Sánchez, C, 1995) |
| "Diagnosis of lymphocytic lymphoma was confirmed." | 1.29 | [Deep morphea-type lesions, first manifestations of lymphocytic lymphoma]. ( Delmas, A; Le Berre, A; Le Leannec, N; Leroy, JP; Plantin, P, 1996) |
| "Paraneoplastic pemphigus is an autoimmune bullous disease described by precise clinical, histological and immunological features presented by Anhalt in 1990." | 1.29 | [Paraneoplastic pemphigus in chronic lymphocytic leukemia]. ( Belaïch, S; Bouscarat, F; Crickx, B; Descamps, V; Fournier, B; Gardin, P; Grossin, M; Joly, P; Le Bozec, P, 1996) |
| "We report a new case of coincidence of chronic lymphocytic leukemia (CLL) and mixed cellularity Hodgkin's disease (HD) in the same lymph node." | 1.29 | [Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study]. ( Fresno, MF; González, M; Herrero, A; Pérez del Río, MJ; Ramírez, A; Veiga, M, 1996) |
| "A further case of listeriosis has recently been described in a man who developed the infection 2 years after successful fludarabine treatment while he had a normal CD4 lymphocyte count." | 1.29 | Late listeriosis after fludarabine plus prednisone treatment. ( Girmenia, C; Mauro, FR; Rahimi, S, 1994) |
| "A total of 795 patients with chronic lymphocytic leukemia who received care at The University of Texas M." | 1.28 | Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. ( Anaissie, E; Elting, L; Kantarjian, H; Keating, M; Kontoyiannis, DP; Robertson, LE, 1992) |
| "One patient each had polyarteritis nodosa, Wegener's granulomatosis, bronchiolitis obliterans with organizing pneumonia, and chronic lymphocytic leukemia with red blood cell aplasia." | 1.28 | Pulmonary complications of combination therapy with cyclophosphamide and prednisone. ( Brock, N; Fisher, W; Sen, RP; Walsh, TE, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (6.02) | 18.7374 |
| 1990's | 92 (36.95) | 18.2507 |
| 2000's | 73 (29.32) | 29.6817 |
| 2010's | 56 (22.49) | 24.3611 |
| 2020's | 13 (5.22) | 2.80 |
| Authors | Studies |
|---|---|
| Leslie, LA | 1 |
| Davids, MS | 1 |
| Rogers, KA | 2 |
| Tyekucheva, S | 1 |
| Wang, Z | 1 |
| Pazienza, S | 1 |
| Renner, SK | 1 |
| Montegaard, J | 1 |
| Ihuoma, U | 1 |
| Lehmberg, TZ | 1 |
| Parry, EM | 1 |
| Wu, CJ | 1 |
| Jacobson, CA | 1 |
| Fisher, DC | 1 |
| Thompson, PA | 1 |
| Brown, JR | 1 |
| Wang, L | 2 |
| Wu, S | 1 |
| Yu, G | 1 |
| Sui, X | 1 |
| Chu, X | 1 |
| Liu, X | 1 |
| Carriles, C | 1 |
| Ordóñez-Fernández, L | 1 |
| Arias-Martínez, A | 1 |
| Menárguez-Blanc, R | 1 |
| Rosado-María, MC | 1 |
| Armaly, Z | 1 |
| Elias, M | 1 |
| Yasin, R | 1 |
| Hamzeh, M | 1 |
| Jabbour, AR | 1 |
| Artoul, S | 1 |
| Saffouri, A | 1 |
| Guthrie, J | 1 |
| King, C | 1 |
| Battle, L | 1 |
| Field, H | 1 |
| Motwani, P | 1 |
| Wong, H | 1 |
| Kaley, J | 1 |
| Shiver, M | 1 |
| Gao, L | 1 |
| Huang, SJ | 1 |
| Gerrie, AS | 1 |
| Young, S | 1 |
| Tucker, T | 1 |
| Bruyere, H | 1 |
| Hrynchak, M | 1 |
| Galbraith, P | 1 |
| Al Tourah, AJ | 1 |
| Dueck, G | 1 |
| Noble, MC | 1 |
| Ramadan, KM | 1 |
| Tsang, P | 1 |
| Hardy, E | 1 |
| Sehn, L | 1 |
| Toze, CL | 1 |
| Aldapt, MB | 1 |
| Soliman, D | 1 |
| Szabados, L | 1 |
| Sharaf Eldean, MZ | 1 |
| Shwaylia, HM | 1 |
| Abdulla, MAJ | 1 |
| Yassin, MA | 1 |
| Marvyin, K | 1 |
| Tjønnfjord, EB | 1 |
| Breland, UM | 1 |
| Tjønnfjord, GE | 1 |
| Cao, L | 1 |
| Wang, F | 1 |
| Du, XY | 1 |
| Zhu, HY | 1 |
| Xu, W | 1 |
| Li, JY | 1 |
| Fan, L | 1 |
| De Mello, RB | 1 |
| Do Vale, ECS | 1 |
| Klintman, J | 1 |
| Appleby, N | 1 |
| Stamatopoulos, B | 2 |
| Ridout, K | 1 |
| Eyre, TA | 4 |
| Robbe, P | 1 |
| Pascua, LL | 1 |
| Knight, SJL | 1 |
| Dreau, H | 1 |
| Cabes, M | 2 |
| Popitsch, N | 1 |
| Ehinger, M | 1 |
| Martín-Subero, JI | 1 |
| Campo, E | 1 |
| Månsson, R | 1 |
| Rossi, D | 1 |
| Taylor, JC | 1 |
| Vavoulis, DV | 1 |
| Schuh, A | 4 |
| Henderson, DC | 1 |
| Barringer, G | 1 |
| Bailey, CAR | 1 |
| Laurain, DA | 1 |
| Sheinbein, DM | 1 |
| Jones, HA | 1 |
| Compton, LA | 1 |
| Rosman, IS | 1 |
| Egoryan, G | 1 |
| Murguia-Fuentes, R | 1 |
| Agab, M | 1 |
| Abou-Ghanem, N | 1 |
| Yanez-Bello, MA | 1 |
| Pyakuryal, B | 1 |
| Trelles-Garcia, DP | 1 |
| Ibrahim, R | 1 |
| Filipiuk, D | 1 |
| Gidron, A | 1 |
| Rodriguez-Nava, G | 1 |
| Yan, J | 1 |
| Cui, F | 1 |
| Zhao, S | 1 |
| Ventarola, DJ | 1 |
| Contard, PC | 1 |
| Phelps, RG | 1 |
| Huang, Y | 1 |
| Ruppert, AS | 1 |
| Salem, G | 1 |
| Stephens, DM | 1 |
| Heerema, NA | 1 |
| Andritsos, LA | 1 |
| Awan, FT | 1 |
| Byrd, JC | 2 |
| Flynn, JM | 1 |
| Maddocks, KJ | 1 |
| Jones, JA | 1 |
| Bastida, JM | 1 |
| Cano-Mozo, MT | 1 |
| Lopez-Cadenas, F | 1 |
| Vallejo, VE | 1 |
| Merchán, S | 1 |
| Santos-Montón, C | 1 |
| González-Calle, D | 1 |
| Carrillo, J | 1 |
| Martín, AA | 1 |
| Torres-Hernández, JA | 1 |
| González, M | 2 |
| Martín-Herrero, F | 1 |
| Pabón, P | 1 |
| González-Porras, JR | 1 |
| Aoyama, Y | 1 |
| Kodaka, T | 1 |
| Zushi, Y | 1 |
| Goto, Y | 1 |
| Tsunemine, H | 1 |
| Itoh, T | 1 |
| Takahashi, T | 1 |
| Wanner, D | 1 |
| Bohn, JP | 1 |
| Rudzki, J | 1 |
| Stockhammer, G | 1 |
| Steurer, M | 1 |
| Omar, M | 1 |
| Gali, V | 1 |
| Santos, A | 1 |
| Huber, M | 1 |
| Parmar, N | 1 |
| Rojas Farias, FE | 1 |
| Martínez-Morán, C | 1 |
| Khedaoui, R | 1 |
| Esteban-Garrido, E | 1 |
| Company-Quiroga, J | 1 |
| Alique-Garcia, S | 1 |
| Hernández-Núñez, A | 1 |
| Borbujo-Martínez, J | 1 |
| Vidal, L | 2 |
| Gurion, R | 2 |
| Shargian, L | 1 |
| Dreyling, M | 4 |
| Gafter-Gvili, A | 2 |
| Kethireddy, N | 1 |
| Boyle, E | 1 |
| Haley, M | 1 |
| Reddy, A | 1 |
| Forouhar, F | 1 |
| Clement, J | 1 |
| Cramer, P | 2 |
| Fink, AM | 2 |
| Busch, R | 3 |
| Eichhorst, B | 2 |
| Wendtner, CM | 3 |
| Pflug, N | 1 |
| Langerbeins, P | 2 |
| Bahlo, J | 1 |
| Goede, V | 1 |
| Schubert, F | 1 |
| Döhner, H | 2 |
| Stilgenbauer, S | 2 |
| Dreger, P | 2 |
| Kneba, M | 1 |
| Böttcher, S | 1 |
| Mayer, J | 1 |
| Hallek, M | 3 |
| Fischer, K | 2 |
| Huang, Q | 1 |
| Magni, M | 1 |
| Di Nicola, M | 1 |
| Patti, C | 1 |
| Scimè, R | 1 |
| Mulè, A | 1 |
| Rambaldi, A | 1 |
| Intermesoli, T | 1 |
| Viero, P | 1 |
| Tarella, C | 1 |
| Gueli, A | 1 |
| Bergui, L | 1 |
| Trentin, L | 1 |
| Barzan, A | 1 |
| Benedetti, F | 1 |
| Ambrosetti, A | 2 |
| Di Raimondo, F | 1 |
| Chiarenza, A | 1 |
| Parvis, G | 1 |
| Billio, A | 1 |
| Attolico, I | 1 |
| Olivieri, A | 1 |
| Montanari, M | 1 |
| Carlo-Stella, C | 2 |
| Matteucci, P | 1 |
| Devizzi, L | 1 |
| Guidetti, A | 1 |
| Viviani, S | 1 |
| Valagussa, P | 1 |
| Gianni, AM | 1 |
| Said, R | 1 |
| Tsimberidou, AM | 1 |
| Aoki, S | 1 |
| DeVito, N | 1 |
| Mui, K | 1 |
| Jassam, Y | 1 |
| Taylor, L | 1 |
| Pilichowska, M | 1 |
| Cossor, F | 1 |
| Satram-Hoang, S | 1 |
| Reyes, C | 1 |
| Hoang, KQ | 1 |
| Momin, F | 1 |
| Skettino, S | 1 |
| Knauf, W | 1 |
| Abenhardt, W | 1 |
| Dörfel, S | 1 |
| Meyer, D | 1 |
| Grugel, R | 1 |
| Münz, M | 1 |
| Hartmann, H | 1 |
| Marschner, N | 1 |
| Kluk, J | 1 |
| Moonim, M | 1 |
| Duran, A | 1 |
| Costa Rosa, J | 1 |
| Cabeçadas, J | 1 |
| Alvarez, R | 1 |
| Cravo, M | 1 |
| Whittaker, S | 1 |
| Robson, A | 1 |
| Olszewski, AJ | 1 |
| Shafqat, H | 1 |
| Ali, S | 1 |
| Anheier, N | 1 |
| Dürig, J | 1 |
| Bergmann, M | 2 |
| Goebeler, ME | 1 |
| Hurtz, HJ | 1 |
| Stauch, MB | 1 |
| Tsang, M | 1 |
| Shanafelt, TD | 2 |
| Call, TG | 2 |
| Ding, W | 1 |
| Chanan-Khan, A | 1 |
| Leis, JF | 1 |
| Nowakowski, GS | 1 |
| Bowen, D | 1 |
| Conte, M | 1 |
| Schwager, SM | 2 |
| Slager, SL | 2 |
| Kay, NE | 3 |
| Hanson, CA | 1 |
| Parikh, SA | 1 |
| Fornecker, LM | 1 |
| Aurran-Schleinitz, T | 1 |
| Michallet, AS | 1 |
| Cazin, B | 4 |
| Guieze, R | 1 |
| Dilhuydy, MS | 1 |
| Zini, JM | 1 |
| Tomowiak, C | 1 |
| Lepretre, S | 2 |
| Cymbalista, F | 1 |
| Brion, A | 3 |
| Feugier, P | 4 |
| Delmer, A | 1 |
| Leblond, V | 2 |
| Ysebaert, L | 1 |
| Clifford, R | 2 |
| Roberts, C | 2 |
| Boyle, L | 2 |
| Francis, A | 1 |
| Dutton, SJ | 1 |
| Streu, E | 1 |
| Polaczek, MM | 1 |
| Zych, J | 1 |
| Opoka, L | 1 |
| Maksymiuk, B | 1 |
| Roszkowski-Sliż, K | 1 |
| Li, Z | 1 |
| Li, F | 1 |
| Yi, S | 1 |
| Gu, Z | 1 |
| Yu, Z | 1 |
| Xu, Y | 1 |
| Feng, X | 1 |
| Liu, W | 1 |
| Zou, D | 1 |
| Qi, J | 1 |
| Zhan, F | 1 |
| Qiu, L | 1 |
| Gajendra, S | 1 |
| Jha, B | 1 |
| Goel, S | 1 |
| Sahni, T | 1 |
| Dorwal, P | 1 |
| Sachdev, R | 1 |
| Han, HJ | 1 |
| Lu, YW | 1 |
| Xia, RX | 1 |
| Carli, G | 1 |
| Visco, C | 1 |
| Falisi, E | 1 |
| Perbellini, O | 1 |
| Novella, E | 1 |
| Giaretta, I | 1 |
| Ferrarini, I | 1 |
| Sandini, A | 1 |
| Alghisi, A | 1 |
| Rodeghiero, F | 1 |
| Bloor, A | 1 |
| Collins, GP | 1 |
| Devereux, S | 2 |
| Follows, G | 1 |
| Fox, CP | 1 |
| Gribben, J | 1 |
| Hillmen, P | 1 |
| Hatton, CS | 1 |
| Littlewood, TJ | 1 |
| McCarthy, H | 1 |
| Murray, J | 1 |
| Pettitt, AR | 1 |
| Soilleux, E | 1 |
| Love, SB | 1 |
| Wotherspoon, A | 1 |
| César, A | 1 |
| Calistru, A | 1 |
| Pardal, J | 1 |
| Magina, S | 1 |
| Mota, A | 1 |
| Azevedo, F | 1 |
| Sławińska, M | 1 |
| Barańska-Rybak, W | 1 |
| Sobjanek, M | 1 |
| Wilkowska, A | 1 |
| Mital, A | 1 |
| Nowicki, R | 1 |
| Galeone, M | 1 |
| Antiga, E | 1 |
| Klepfish, A | 2 |
| Rachmilewitz, EA | 1 |
| Kotsianidis, I | 1 |
| Patchenko, P | 1 |
| Schattner, A | 1 |
| Vlachaki, E | 1 |
| Tselios, K | 1 |
| Charalambidou, S | 1 |
| Ioannidou, E | 1 |
| Klonizakis, I | 1 |
| Mutluay, R | 1 |
| Aki, SZ | 1 |
| Erten, Y | 1 |
| Konca, C | 1 |
| Yagci, M | 1 |
| Barit, G | 1 |
| Sindel, S | 1 |
| Kovacs, JA | 1 |
| Masur, H | 1 |
| Levitt, MJ | 1 |
| Gharibo, M | 1 |
| Strair, R | 1 |
| Schaar, D | 1 |
| Rubin, A | 1 |
| Bertino, JR | 1 |
| Koffi, KG | 1 |
| Nanho, DC | 1 |
| Tolo, A | 1 |
| N'Dathz, E | 1 |
| Kouakou, B | 2 |
| Meite, N | 1 |
| Ayemou, R | 1 |
| Sanogo, I | 2 |
| Smolej, L | 2 |
| Belada, D | 1 |
| Cermanová, M | 1 |
| Maisnar, V | 1 |
| Lunáková, E | 1 |
| Bowen, DA | 1 |
| Reinalda, MS | 1 |
| Rabe, KG | 1 |
| Zent, CS | 2 |
| Osterborg, A | 1 |
| Karlsson, C | 2 |
| Lundin, J | 2 |
| Vasilj, A | 1 |
| Kojić-Katović, S | 1 |
| Maricević, I | 1 |
| Zokvić, E | 1 |
| Kelcec, IB | 1 |
| Tomas, D | 1 |
| Curić-Jurić, S | 1 |
| Kriwalsky, MS | 1 |
| Schroers, R | 1 |
| Stricker, I | 1 |
| Hollstein, S | 1 |
| Kunkel, M | 1 |
| Bauer, K | 2 |
| Herbst, C | 1 |
| Brillant, C | 1 |
| Monsef, I | 2 |
| Kluge, S | 1 |
| Skoetz, N | 2 |
| Engert, A | 2 |
| Coppola, N | 1 |
| Masiello, A | 1 |
| Tonziello, G | 1 |
| Macera, M | 1 |
| Iodice, V | 1 |
| Caprio, N | 1 |
| Pasquale, G | 1 |
| Liu, EB | 1 |
| Zhang, PH | 1 |
| Li, ZQ | 1 |
| Sun, Q | 1 |
| Yang, QY | 1 |
| Fang, LH | 1 |
| Sun, FJ | 1 |
| Qiu, LG | 1 |
| Chen, DB | 1 |
| Song, QJ | 1 |
| Shen, DH | 1 |
| Chu, DT | 1 |
| Giardino, AA | 1 |
| O'Regan, K | 1 |
| Jagannathan, JP | 1 |
| Elco, C | 1 |
| Ramaiya, N | 1 |
| Lacasce, A | 1 |
| Polliack, A | 1 |
| Tadmor, T | 1 |
| Sutton, L | 1 |
| Chevret, S | 4 |
| Tournilhac, O | 1 |
| Diviné, M | 2 |
| Corront, B | 1 |
| Eghbali, H | 1 |
| Van Den Neste, E | 1 |
| Michallet, M | 1 |
| Maloisel, F | 1 |
| Bouabdallah, K | 1 |
| Decaudin, D | 1 |
| Berthou, C | 1 |
| Brice, P | 1 |
| Gonzalez, H | 1 |
| Chapiro, E | 1 |
| Radford-Weiss, I | 1 |
| Leporrier, N | 1 |
| Maloum, K | 3 |
| Nguyen-Khac, F | 1 |
| Davi, F | 2 |
| Lejeune, J | 1 |
| Merle-Béral, H | 1 |
| Leporrier, M | 4 |
| Aymard, B | 1 |
| Beghoura, R | 1 |
| Molina, TJ | 1 |
| Montserrat, E | 2 |
| Gribben, JG | 1 |
| Mahé, B | 2 |
| Kolb, B | 1 |
| Audhuy, B | 1 |
| Colombat, P | 1 |
| Maisonneuve, H | 1 |
| Foussard, C | 1 |
| Bureau, A | 1 |
| Ferrand, C | 1 |
| Lesesve, JF | 1 |
| Béné, MC | 1 |
| Gaertner, EM | 1 |
| Switlyk, SA | 1 |
| Sadrzadeh, H | 1 |
| Hasserjian, R | 1 |
| Fathi, AT | 1 |
| Rancea, M | 1 |
| Hübel, K | 1 |
| Raanani, P | 1 |
| Shpilberg, O | 1 |
| Garg, S | 1 |
| Garg, MS | 1 |
| Basmaji, N | 1 |
| Schmitt, B | 1 |
| Franke, A | 2 |
| Pasold, R | 2 |
| Schlag, R | 1 |
| Hopfinger, G | 1 |
| Hiddemann, W | 3 |
| Emmerich, B | 2 |
| Robak, T | 10 |
| Boński, JZ | 1 |
| Kasznicki, M | 7 |
| Góra-Tybor, J | 5 |
| Hellmann, A | 5 |
| Konopka, L | 6 |
| Dmoszyńska, A | 7 |
| Dwilewicz-Trojaczek, J | 4 |
| Wołowiec, D | 1 |
| Gupta, N | 1 |
| Kavuru, S | 1 |
| Patel, D | 1 |
| Janson, D | 1 |
| Driscoll, N | 1 |
| Ahmed, S | 1 |
| Rai, KR | 2 |
| Saxena, A | 2 |
| Moshynska, O | 2 |
| Sankaran, K | 2 |
| Viswanathan, S | 2 |
| Sheridan, DP | 2 |
| Chrissos, D | 1 |
| Kalmantis, T | 1 |
| Belegrati, M | 1 |
| Katsaros, A | 1 |
| Tapanlis, E | 1 |
| Katsimichas, A | 1 |
| Triantafillou, G | 1 |
| Kallikazaros, I | 1 |
| Chehal, A | 1 |
| Haidar, JH | 1 |
| Jabbour, R | 1 |
| Yammout, B | 1 |
| Bazarbachi, A | 1 |
| Choueiri, T | 1 |
| Lichtin, AE | 1 |
| Adiga, GU | 1 |
| Abebe, L | 1 |
| Wiernik, PH | 2 |
| Gergely, L | 1 |
| Váróczy, L | 1 |
| Vadász, G | 1 |
| Remenyik, E | 1 |
| Illés, A | 1 |
| Smyth, EF | 1 |
| Bartlett, RJ | 1 |
| Shields, ML | 1 |
| White, TJ | 1 |
| Wengraf, C | 1 |
| Kyasa, MJ | 1 |
| Parrish, RS | 1 |
| Schichman, SA | 1 |
| FREYMANN, JG | 1 |
| VANDER, JB | 1 |
| BURRELL, SB | 1 |
| MARLER, EA | 1 |
| BRUNNER, K | 2 |
| KEISER, G | 2 |
| MARTZ, G | 2 |
| Rathore, R | 1 |
| Elfenbein, GJ | 1 |
| Matsunaga, T | 1 |
| Kogawa, K | 1 |
| Fujimi, A | 1 |
| Takizawa, K | 1 |
| Takahira, N | 1 |
| Takemoto, N | 1 |
| Tanaka, I | 1 |
| Akiyama, T | 1 |
| Sato, T | 1 |
| Takayama, T | 1 |
| Terui, T | 1 |
| Sakamaki, S | 1 |
| Niitsu, Y | 1 |
| Stiefelhagen, P | 1 |
| Mauro, FR | 3 |
| Zinzani, P | 1 |
| Zaja, F | 1 |
| Gentile, M | 2 |
| Vegna, ML | 1 |
| Stefoni, V | 1 |
| Marin, L | 1 |
| Fanin, R | 1 |
| Baccarani, M | 1 |
| Tura, S | 1 |
| Mandelli, F | 2 |
| Tandon, P | 1 |
| Blonski, JZ | 4 |
| Ceglarek, B | 4 |
| Komarnicki, M | 3 |
| Lewandowski, K | 4 |
| Moskwa, A | 1 |
| Sokołowska, B | 1 |
| Dwilewicz-Trojaczek, A | 1 |
| Tomaszewska, A | 2 |
| Sułek, K | 2 |
| Całbecka, M | 1 |
| Oken, MM | 1 |
| Lee, S | 1 |
| Knospe, W | 1 |
| Cassileth, PA | 1 |
| Vavricka, SR | 1 |
| Halter, J | 1 |
| Hechelhammer, L | 1 |
| Himmelmann, A | 1 |
| Ziakas, PD | 1 |
| Giannouli, S | 1 |
| Psimenou, E | 1 |
| Nakopoulou, L | 1 |
| Voulgarelis, M | 1 |
| Shvidel, L | 2 |
| Shtalrid, M | 2 |
| Berrebi, A | 2 |
| Skotñicki, A | 1 |
| Fernyhough, LJ | 1 |
| Romeril, K | 1 |
| Carter, J | 1 |
| Ritchie, DS | 1 |
| Herold, M | 1 |
| Schulze, A | 1 |
| Niederwieser, D | 1 |
| Fricke, HJ | 1 |
| Richter, P | 1 |
| Freund, M | 2 |
| Ismer, B | 1 |
| Dachselt, K | 1 |
| Boewer, C | 1 |
| Schirmer, V | 1 |
| Weniger, J | 1 |
| Winkelmann, C | 1 |
| Klinkenstein, C | 1 |
| Schulze, M | 1 |
| Arzberger, H | 1 |
| Bremer, K | 1 |
| Hahnfeld, S | 1 |
| Schwarzer, A | 1 |
| Müller, C | 4 |
| Robak, E | 1 |
| Kordek, R | 1 |
| Wawrzyniak, E | 1 |
| Bartkowiak, J | 1 |
| Bednarek, A | 1 |
| Constantinou, M | 1 |
| Kałuzewski, B | 1 |
| Błoński, JZ | 3 |
| Wojtaszko, M | 1 |
| Skotnicki, AB | 5 |
| Nowak, W | 3 |
| Zdziarska, B | 4 |
| Boguradzki, P | 1 |
| Kuliczkowski, K | 2 |
| Warzocha, K | 1 |
| Padate, BP | 1 |
| Keidan, J | 1 |
| Alzamora, MG | 1 |
| Schmidli, M | 1 |
| Hess, U | 2 |
| Cathomas, R | 1 |
| von Moos, R | 1 |
| Xia, ZJ | 1 |
| Wang, FH | 1 |
| Huang, HQ | 1 |
| Luo, HY | 1 |
| Li, YH | 1 |
| Lin, TY | 1 |
| Jiang, WQ | 1 |
| Guan, ZZ | 1 |
| Al-Tourah, AJ | 1 |
| Tsang, PW | 1 |
| Skinnider, BF | 1 |
| Hoskins, PJ | 1 |
| Cervigón, I | 1 |
| Gargallo, AB | 1 |
| Bahillo, C | 1 |
| Martínez-Amo, JL | 1 |
| Orradre, JL | 1 |
| Muñoz-Madero, V | 1 |
| García-Almagro, D | 1 |
| Babu Rao, V | 1 |
| Kerketta, L | 1 |
| Madkaikar, M | 1 |
| Farah, J | 1 |
| Ghosh, K | 1 |
| Milojković, D | 1 |
| Aldouri, M | 1 |
| Pagliuca, A | 1 |
| Mufti, GJ | 1 |
| Nickenig, C | 1 |
| Hoster, E | 1 |
| Ludwig, WD | 1 |
| Dörken, B | 1 |
| Huber, C | 1 |
| Ganser, A | 1 |
| Trümper, L | 1 |
| Forstpointner, R | 1 |
| Unterhalt, M | 1 |
| Laurencet, F | 1 |
| Ballabeni, P | 1 |
| Rufener, B | 1 |
| Cerny, T | 1 |
| Fey, M | 1 |
| Luthi, JM | 1 |
| Plancherel, C | 1 |
| Zulian, GB | 2 |
| Cummins, DL | 1 |
| Mimouni, D | 1 |
| Tzu, J | 1 |
| Owens, N | 1 |
| Anhalt, GJ | 2 |
| Meyerle, JH | 1 |
| Molina Garrido, MJ | 1 |
| Guillén Ponce, C | 1 |
| Escolano Hortelano, CM | 1 |
| Sabín Domínguez, MP | 1 |
| Mora Rufete, A | 1 |
| Carrato Mena, A | 1 |
| Hansson, L | 1 |
| Celsing, F | 1 |
| Lu, Y | 1 |
| Sun, LR | 1 |
| Pang, XY | 1 |
| Lu, ZH | 1 |
| Sui, AH | 1 |
| Koffi, G | 1 |
| Ndiaye, FS | 1 |
| Ndathz, E | 1 |
| Sangare, A | 1 |
| Alexandrescu, DT | 1 |
| Kiselow, MA | 1 |
| Rassnick, KM | 1 |
| McDonough, SP | 1 |
| Goldstein, RE | 1 |
| Simpson, KW | 1 |
| Weinkle, TK | 1 |
| Erb, HN | 1 |
| Lesesve, J | 1 |
| Palmiéri, A | 1 |
| Garand, R | 1 |
| Siegert, W | 1 |
| Nerl, C | 1 |
| Engelhard, M | 1 |
| Brittinger, G | 1 |
| Tiemann, M | 1 |
| Parwaresch, R | 1 |
| Heinz, R | 1 |
| Huhn, D | 2 |
| Bosanquet, AG | 1 |
| McCann, SR | 1 |
| Crotty, GM | 1 |
| Mills, MJ | 1 |
| Catovsky, D | 2 |
| Zeidman, A | 1 |
| Yarmolovsky, A | 1 |
| Djaldetti, M | 1 |
| Mittelman, M | 1 |
| van Kooten, C | 1 |
| Rensink, I | 1 |
| Aarden, L | 1 |
| van Oers, R | 1 |
| Wallner, J | 1 |
| Gisslinger, H | 1 |
| Gisslinger, B | 1 |
| Gsur, A | 1 |
| Götzl, M | 1 |
| Zöchbauer, S | 1 |
| Pirker, R | 1 |
| Girmenia, C | 1 |
| Rahimi, S | 1 |
| Schaller, J | 1 |
| Rohwedder, A | 1 |
| Breier, B | 1 |
| Werchau, H | 1 |
| Ueda, T | 1 |
| Yamauchi, T | 1 |
| Kageyama, S | 1 |
| Tsuzuki, M | 1 |
| Kawakami, S | 1 |
| Yonese, J | 1 |
| Kawai, T | 1 |
| Lerner, D | 1 |
| Esteves, C | 1 |
| De Oliveira, MS | 1 |
| Cleveland, KO | 1 |
| Gelfand, MS | 1 |
| Mohr, M | 1 |
| Kingreen, D | 1 |
| Rühl, H | 1 |
| Mateo, J | 1 |
| Martino, R | 1 |
| Borrell, M | 1 |
| Garí, M | 1 |
| Casas, F | 1 |
| Fontcuberta, J | 1 |
| Chatelut, E | 1 |
| Gualano, V | 1 |
| De Forni, M | 1 |
| Huguet, F | 1 |
| Attal, M | 1 |
| Canal, P | 1 |
| Laurent, G | 1 |
| O'Brien, S | 2 |
| Kantarjian, H | 4 |
| Beran, M | 1 |
| Smith, T | 1 |
| Koller, C | 1 |
| Estey, E | 1 |
| Robertson, LE | 3 |
| Lerner, S | 2 |
| Keating, M | 2 |
| Molica, S | 4 |
| Bierman, PJ | 1 |
| Warkentin, P | 1 |
| Hutchins, MR | 1 |
| Klassen, LW | 1 |
| Binet, JL | 4 |
| Shaklai, S | 1 |
| Bairey, O | 1 |
| Blickstein, D | 1 |
| Prokocimer, M | 1 |
| Hadar, H | 1 |
| Lahav, M | 1 |
| Sulkes, J | 1 |
| Shaklai, M | 1 |
| Astrow, AB | 1 |
| Johnson, S | 1 |
| Smith, AG | 1 |
| Löffler, H | 2 |
| Osby, E | 1 |
| Juliusson, G | 1 |
| Wyld, PJ | 1 |
| Cesana, C | 1 |
| Mangoni, L | 1 |
| Almici, C | 1 |
| Giachetti, R | 1 |
| Zappa, M | 1 |
| Rizzoli, V | 1 |
| Levato, D | 1 |
| Di Renzo, N | 1 |
| La Sala, A | 1 |
| Carotenuto, M | 1 |
| Newcom, SR | 1 |
| Cano, I | 1 |
| Martinez, J | 1 |
| Quevedo, E | 1 |
| Pinilla, J | 1 |
| Martin-Recio, A | 1 |
| Rodriguez, A | 1 |
| Castañeda, A | 1 |
| López, R | 1 |
| Pérez-Piño, T | 1 |
| Hernández-Navarro, F | 1 |
| Dean, MG | 1 |
| Cunningham, I | 1 |
| Dao, LP | 1 |
| Cole, I | 1 |
| Mulligan S, P | 1 |
| Amigo, ML | 1 |
| Revilla, R | 1 |
| Sánchez, C | 1 |
| del Cañizo, C | 1 |
| Caballero, D | 1 |
| San Miguel, JF | 1 |
| Nezu, M | 1 |
| Kawano, E | 1 |
| Ishii, H | 1 |
| Nishimura, M | 1 |
| Hirasawa, A | 1 |
| Hashimoto, S | 1 |
| Morio, S | 1 |
| Aotsuka, N | 1 |
| Nakamura, H | 1 |
| Asai, T | 1 |
| Saito, Y | 1 |
| Oh, H | 1 |
| Ribrag, V | 1 |
| Massade, L | 1 |
| Faussat, AM | 1 |
| Dreyfus, F | 1 |
| Bayle, C | 1 |
| Gouyette, A | 1 |
| Marie, JP | 1 |
| Itälä, M | 2 |
| Remes, K | 2 |
| Plantin, P | 1 |
| Le Leannec, N | 1 |
| Delmas, A | 1 |
| Le Berre, A | 1 |
| Leroy, JP | 1 |
| Fournier, B | 1 |
| Bouscarat, F | 1 |
| Le Bozec, P | 1 |
| Joly, P | 2 |
| Gardin, P | 1 |
| Grossin, M | 1 |
| Descamps, V | 1 |
| Crickx, B | 1 |
| Belaïch, S | 1 |
| Pérez del Río, MJ | 1 |
| Fresno, MF | 1 |
| Ramírez, A | 1 |
| Veiga, M | 1 |
| Herrero, A | 1 |
| Levin, M | 1 |
| Aziz, M | 1 |
| Opitz, L | 1 |
| Cacoub, P | 1 |
| Ginsburg, C | 1 |
| Tazi, Z | 1 |
| Beaufils, H | 1 |
| Charlotte, F | 1 |
| Carde, P | 1 |
| Godeau, P | 1 |
| Hequet, O | 1 |
| de Jaureguiberry, JP | 1 |
| Jaubert, D | 1 |
| Gisserot, O | 1 |
| Muzellec, Y | 1 |
| Brisou, P | 1 |
| Jaksic, B | 1 |
| Brugiatelli, M | 1 |
| Krc, I | 1 |
| Losonczi, H | 1 |
| Holowiecki, J | 2 |
| Planinc-Peraica, A | 1 |
| Kusec, R | 1 |
| Morabito, F | 1 |
| Iacopino, P | 1 |
| Lutz, D | 1 |
| Braczkowski, R | 1 |
| Zubelewicz, B | 1 |
| Muc-Wierzgoń, M | 1 |
| Baranowski, M | 1 |
| Shehab, TM | 1 |
| Kaminski, MS | 1 |
| Lok, AS | 1 |
| Vanhatalo, S | 1 |
| Emilia, G | 1 |
| Luppi, M | 1 |
| Ferrari, MG | 1 |
| Barozzi, P | 1 |
| Marasca, R | 1 |
| Torelli, G | 1 |
| Antich Rojas, J | 1 |
| Balaguer, H | 1 |
| Cladera, A | 1 |
| Akin, C | 1 |
| Hansen, P | 1 |
| Janckila, A | 1 |
| Ly, B | 1 |
| Hammerstrøm, J | 1 |
| Bergheim, J | 1 |
| Dahl, IM | 1 |
| Grøttum, KA | 1 |
| Lødemel, B | 1 |
| Biondi, C | 1 |
| Cotorruelo, C | 1 |
| Chernigoy, S | 1 |
| Racca, A | 1 |
| Dighiero, G | 3 |
| Desablens, B | 3 |
| Navarro, M | 1 |
| Leblay, R | 1 |
| Jaubert, J | 2 |
| Lepeu, G | 1 |
| Dreyfus, B | 2 |
| Travade, P | 3 |
| Błasińska-Morawiec, M | 2 |
| Krykowski, E | 2 |
| Trepińska, E | 1 |
| Kaźmierczuk, M | 1 |
| Hansz, J | 2 |
| Roliński, J | 1 |
| Nowak, WS | 1 |
| Kotlarek-Haus, S | 2 |
| Urasiński, I | 2 |
| Comerma-Coma, MI | 1 |
| Sans-Boix, A | 1 |
| Tuset-Andújar, E | 1 |
| Andreu-Navarro, J | 1 |
| Pérez-Ruiz, A | 1 |
| Naval-Marcos, I | 1 |
| von Neuhoff, N | 1 |
| Kuse, R | 1 |
| Sonnen, R | 1 |
| Glass, B | 1 |
| Uharek, L | 1 |
| Schoch, R | 1 |
| Schmitz, N | 1 |
| Christodoulopoulos, G | 1 |
| Salles, B | 1 |
| Panasci, L | 1 |
| Anaissie, EJ | 1 |
| Kontoyiannis, DP | 2 |
| Robertson, L | 1 |
| Keating, MJ | 3 |
| Müller, MR | 1 |
| Buschfort, C | 1 |
| Thomale, J | 1 |
| Lensing, C | 1 |
| Rajewsky, MF | 1 |
| Seeber, S | 1 |
| Taha, HM | 1 |
| Narasihman, P | 1 |
| Venkatesh, L | 1 |
| Cawley, M | 1 |
| Kaplan, B | 1 |
| Vlasveld, LT | 1 |
| Pauwels, P | 1 |
| Ermens, AA | 1 |
| Aarnoudse, WH | 1 |
| Ooms, HW | 1 |
| Haak, HR | 1 |
| Shimoni, A | 1 |
| Sigler, E | 1 |
| Laurencet, FM | 1 |
| Guetty-Alberto, M | 1 |
| Iten, PA | 1 |
| Betticher, DC | 1 |
| Alberto, P | 1 |
| Urbańska-Ryś, H | 1 |
| Nousari, HC | 1 |
| Brodsky, RA | 1 |
| Jones, RJ | 1 |
| Grever, MR | 2 |
| Belcheva, A | 1 |
| Sen, K | 1 |
| Kalaycio, M | 1 |
| Ember, I | 1 |
| Kiss, I | 1 |
| Raposa, T | 1 |
| Gopal, AK | 1 |
| Schuetze, SM | 1 |
| Maloney, DG | 1 |
| Weiden, PL | 1 |
| Calvo Villas, J | 1 |
| Ramírez Sánchez, M | 1 |
| Sicilia Guillén, F | 1 |
| Gómez-Román, JJ | 1 |
| Pérez-Montes, R | 1 |
| Pérez-Expósito, MA | 1 |
| Richard, C | 1 |
| Baro, J | 1 |
| Val-Bernal, JF | 1 |
| Soroka-Wojtaszko, M | 1 |
| Potoczek, S | 2 |
| Kroll, R | 1 |
| Grieb, P | 2 |
| Várkonyi, J | 1 |
| Zalatnai, A | 1 |
| Timár, J | 1 |
| Matolcsi, A | 1 |
| Falus, A | 1 |
| Bencsáth, M | 1 |
| László, V | 1 |
| Pócsik, E | 1 |
| Kotlán, B | 1 |
| Császár, A | 1 |
| Miljić, P | 1 |
| Milosević-Jovicić, N | 1 |
| Antunović, P | 1 |
| Bosković, D | 1 |
| Basara, N | 1 |
| Rolović, Z | 1 |
| Blasińska-Morawiec, M | 1 |
| Mrugala-Spiewak, H | 1 |
| Maj, S | 1 |
| Krebs, T | 1 |
| Zimmerli, S | 1 |
| Bodmer, T | 1 |
| Lämmle, B | 1 |
| Sivakumaran, M | 1 |
| Arweiler-Harbeck, D | 1 |
| Bremkamp, S | 1 |
| Shinn, C | 1 |
| Willis, CR | 1 |
| Flinn, IW | 1 |
| Lehman, T | 1 |
| Sausville, E | 1 |
| Lucas, D | 1 |
| Błoński , JZ | 1 |
| Rivollier, C | 1 |
| Vaillant, L | 1 |
| Machet, MC | 1 |
| Martin, L | 1 |
| Jan, V | 1 |
| Huttenberger, B | 1 |
| Lorette, G | 1 |
| Levy, V | 1 |
| Porcher, R | 1 |
| Delabarre, F | 1 |
| Bohn, S | 1 |
| Ebnöther, M | 1 |
| Tefferi, A | 2 |
| Li, CY | 1 |
| Reeder, CB | 1 |
| Geyer, SM | 1 |
| Allmer, C | 1 |
| Levitt, R | 1 |
| Michalak, JC | 1 |
| Addo, F | 1 |
| Krook, JE | 1 |
| Witzig, TE | 1 |
| Schaefer, PL | 1 |
| Mailliard, JA | 1 |
| Boudjerra, N | 1 |
| Rapp, MJ | 1 |
| Autrand, C | 1 |
| Chastang, C | 2 |
| Liso, V | 1 |
| Capalbo, S | 1 |
| Pogliani, E | 1 |
| Battista, C | 1 |
| Broccia, G | 1 |
| Montillo, M | 1 |
| Cuneo, A | 1 |
| Leoni, P | 1 |
| Specchia, G | 1 |
| Castoldi, G | 1 |
| Rossi, G | 1 |
| Pelizzari, A | 1 |
| Motta, M | 1 |
| Puoti, M | 1 |
| el Omari-Alaoui, H | 1 |
| Kebdani, T | 1 |
| Benjaafar, N | 1 |
| el Ghazi, E | 1 |
| Erriahni, H | 1 |
| el Gueddari, BK | 1 |
| Mancini, F | 1 |
| Giannarelli, D | 1 |
| Guarini, A | 1 |
| De Propriis, MS | 1 |
| Cerretti, R | 1 |
| Foa, R | 1 |
| Strippoli, GF | 1 |
| Manno, C | 1 |
| Rossini, M | 1 |
| Occhiogrosso, G | 1 |
| Maiorano, E | 1 |
| Schena, FP | 1 |
| Volk, AL | 1 |
| Vannucci, SA | 1 |
| Cook, W | 1 |
| Thompson, KA | 1 |
| Listinsky, CM | 1 |
| Vuillier, F | 1 |
| Claisse, JF | 1 |
| Vandenvelde, C | 1 |
| Magnac, C | 1 |
| Anaissie, E | 1 |
| Elting, L | 1 |
| Nakano, M | 1 |
| Kawanishi, Y | 1 |
| Kuge, S | 1 |
| Kuriyama, Y | 1 |
| Kuwabara, S | 1 |
| Yaguchi, M | 1 |
| Toyama, K | 1 |
| Huh, YO | 1 |
| Butler, JJ | 1 |
| Pugh, WC | 1 |
| Hirsch-Ginsberg, C | 1 |
| Stass, S | 1 |
| Sumimura, J | 1 |
| Miyata, M | 1 |
| Nakao, K | 1 |
| Kamiike, W | 1 |
| Yamaguchi, T | 1 |
| Matsuda, H | 1 |
| Phyliky, RL | 1 |
| Ferrara, F | 2 |
| Rametta, V | 2 |
| Mele, G | 2 |
| Antinolfi, I | 1 |
| Mettivier, V | 1 |
| Cimino, R | 1 |
| Chikkappa, G | 1 |
| Pasquale, D | 1 |
| Zarrabi, MH | 1 |
| Weiler, RJ | 1 |
| Divakara, M | 1 |
| Tsan, MF | 1 |
| Gunsilius, E | 1 |
| Hülser, PJ | 1 |
| Heimpel, H | 1 |
| Kornhuber, HH | 1 |
| Seifried, E | 1 |
| Núñez, E | 1 |
| Solano, D | 1 |
| Arreita, A | 1 |
| Franco-Vicario, R | 1 |
| Miguel, F | 1 |
| Montero, S | 1 |
| Caballín, MR | 1 |
| Coll, MD | 1 |
| Besses, C | 1 |
| Woessner, S | 1 |
| Egozcue, J | 1 |
| Solé, F | 1 |
| Sen, RP | 1 |
| Walsh, TE | 1 |
| Fisher, W | 1 |
| Brock, N | 1 |
| Arai, N | 1 |
| Hara, A | 1 |
| Umeda, M | 1 |
| Shirai, T | 1 |
| Hollander, SL | 1 |
| Areal Méndez, C | 1 |
| Lite Alvarez, JM | 1 |
| Sánchez Varela, JM | 1 |
| Gastaldi, R | 1 |
| Monarca, B | 1 |
| Coluzzi, S | 1 |
| De Rossi, G | 1 |
| Raphael, B | 1 |
| Andersen, JW | 1 |
| Silber, R | 1 |
| Oken, M | 1 |
| Moore, D | 1 |
| Bennett, J | 1 |
| Bonner, H | 1 |
| Hahn, R | 1 |
| Knospe, WH | 1 |
| Mazza, J | 1 |
| Tumakov, VA | 1 |
| Abdulkadyrov, KM | 1 |
| Rugal', VI | 1 |
| Karpenkov, MV | 1 |
| Ved', VV | 1 |
| Brodovskiĭ, AF | 1 |
| Svojgrová, M | 1 |
| Slechtová, J | 1 |
| Koza, V | 1 |
| Panzner, P | 1 |
| Cepelák, V | 1 |
| Bookman, MA | 1 |
| Lardelli, P | 1 |
| Jaffe, ES | 1 |
| Duffey, PL | 1 |
| Longo, DL | 1 |
| Poulios, C | 1 |
| Pinto, PC | 1 |
| Hu, E | 1 |
| Bernstein-Singer, M | 1 |
| Pinter-Brown, L | 1 |
| Govindarajan, S | 1 |
| Bennett, JM | 1 |
| Smetana, K | 1 |
| Lejmar, J | 1 |
| Micánková, M | 1 |
| Klener, P | 1 |
| Wilkinson, AH | 1 |
| Smith, JL | 1 |
| Hunsicker, LG | 1 |
| Tobacman, J | 1 |
| Kapelanski, DP | 1 |
| Johnson, M | 1 |
| Wright, FH | 1 |
| Behrendt, DM | 1 |
| Corry, RJ | 1 |
| Del Vecchio, L | 1 |
| Ronconi, F | 1 |
| Montuori, R | 1 |
| Marigil, MA | 1 |
| Pardo-Mindan, FJ | 1 |
| Cuesta, B | 1 |
| Rocha, E | 1 |
| Idoate, MA | 1 |
| Gómez-Bezares, MC | 1 |
| Case, DC | 1 |
| Boyd, M | 1 |
| Hayes, DM | 1 |
| Dorsk, BM | 1 |
| Alcalá, A | 1 |
| Alonso, C | 1 |
| Besalduch, J | 1 |
| Moraleda, JM | 1 |
| García-Conde, J | 1 |
| Gutierrez, M | 1 |
| Gomis, F | 1 |
| Garijo, J | 1 |
| Guzmán, MC | 1 |
| Hansen, MM | 1 |
| Andersen, E | 1 |
| Christensen, BE | 1 |
| Christiansen, I | 1 |
| Geisler, C | 1 |
| Kristensen, D | 1 |
| Jensen, KB | 1 |
| Junker, P | 1 |
| Bénichou, J | 1 |
| Fooks, J | 1 |
| Richards, S | 1 |
| Jootar, S | 1 |
| Nitiyanant, P | 1 |
| Ratanaprakarn, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Venetoclax Plus Dose-adjusted R-EPOCH or R-CHOP for Richter's Syndrome[NCT03054896] | Phase 2 | 67 participants (Anticipated) | Interventional | 2017-03-08 | Recruiting | ||
| A Phase II, Randomised Study of CHOP-R in Combination With Acalabrutinib Compared to CHOP-R in Patients With Newly Diagnosed Richter's Syndrome and a Platform for Initial Investigations Into Activity of Novel Treatments in Relapsed/Refractory and Newly Di[NCT03899337] | Phase 2 | 105 participants (Anticipated) | Interventional | 2019-07-23 | Recruiting | ||
| Epidemiological Registry Describing Treatment Reality and Therapy Modalities of Patients With Malignant Lymphatic Systemic Diseases (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma) Requiring Therapy.[NCT00889798] | 3,795 participants (Actual) | Observational [Patient Registry] | 2009-04-30 | Completed | |||
| CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)[NCT00309881] | Phase 2 | 75 participants (Anticipated) | Interventional | 2003-04-30 | Completed | ||
| Single Arm NCRI Feasibility Study of CHOP in Combination With Ofatumumab in Induction and Maintenance for Patients With Newly Diagnosed Richter's Syndrome[NCT01171378] | Phase 2 | 43 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| Studies of Human Pneumocystis Infection[NCT00342589] | 1,500 participants (Anticipated) | Observational | 1999-09-28 | Recruiting | |||
| Rituximab in the Treatment of Patients With Bullous Pemphigoid[NCT00286325] | Phase 1/Phase 2 | 8 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
| A Multicenter Phase II Study Evaluating BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for First and Second Chemosensitive Relapses in Patients With Follicular Lymphoma[NCT02008006] | Phase 2 | 21 participants (Actual) | Interventional | 2014-07-09 | Terminated (stopped due to Insufficient recruitment and unavailability of the treatment) | ||
| Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies[NCT00818961] | Phase 2 | 36 participants (Actual) | Interventional | 2005-05-31 | Terminated (stopped due to terminated early due to meeting end point with fewer patients than anticipated) | ||
| Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated CLL With Four or Six Cycles of Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide Followed by Lenalidomide Consolidation/ Maintenance[NCT01723839] | Phase 2 | 21 participants (Actual) | Interventional | 2012-02-22 | Completed | ||
| A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)[NCT00779883] | Phase 1 | 9 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| A Phase 1B Extension Trial to Allow Repeat Dosing of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35) in Subjects Previously Treated in MDACC Protocol 2004-0914[NCT00783588] | Phase 1 | 4 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| Phase Ib Dose Finding Study of ABT-199 (A-1195425.0) Plus Ibrutinib (PCI-32765) and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell NHL (DLBCL)[NCT03136497] | Phase 1 | 10 participants (Actual) | Interventional | 2017-09-05 | Active, not recruiting | ||
| Phase III Randomized Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Early Stage CLL With High Risk of Early Disease Progression[NCT04178798] | Phase 3 | 22 participants (Actual) | Interventional | 2019-12-09 | Active, not recruiting | ||
| Immune Reconstitution With Blinatumomab Expanded T-cells (BET) After First-line Treatment With Fludarabine-Cyclophosphamide-Rituximab or Bendamustine-Rituximab in CD20+ Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia: a Phase I Study[NCT03823365] | Phase 1 | 19 participants (Actual) | Interventional | 2018-12-17 | Active, not recruiting | ||
| Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis[NCT00001586] | Phase 2 | 105 participants (Actual) | Interventional | 1997-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Peripheral blood B cell number at week 24 compared to B cell number at week 0 (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | B cells per microliter (Median) |
|---|---|
| Treated | 3.99 |
IgG antibodies against BP 180 measured in units (by ELISA) for each participant at week 0 compared to value at week 24, (NCT00286325)
Timeframe: Week 0 and at 24 weeks
| Intervention | Elisa Units (Median) |
|---|---|
| Treated | 40.5 |
The first study visit in which patient reported and was confirmed to have no new blister or lesion formation . (NCT00286325)
Timeframe: 1 year
| Intervention | Days (Median) |
|---|---|
| Treated | 57 |
Subject systemic corticosteroid dosage at week 24 was 25% of starting dose or 10 mg/day of prednisone or less (NCT00286325)
Timeframe: 24 weeks
| Intervention | participants (Number) |
|---|---|
| Treated | 7 |
The primary safety endpoint is the occurrence of treatment emergent adverse events including infections, infusion reactions and disease progression. These were determined by clinical evaluation and laboratory questions. Disease progression is defined as development of new blisters despite therapy. These are reported as the number of participants with a study related SAE. (NCT00286325)
Timeframe: 1 year
| Intervention | participants (Number) | ||
|---|---|---|---|
| Treatment emergent adverse events | Infusion reactions | Disease Progression | |
| Treated | 0 | 0 | 1 |
Complete donor chimerism (defined as >/= 95% donor cells in peripheral blood CD3+ and CD33+ was measured. (NCT00818961)
Timeframe: 2 years
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 26 |
The number of patients experiencing neutrophil recovery post transplant (NCT00818961)
Timeframe: Day 100
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 35 |
Number of patients who died of non-relapse causes at one year. this is in clusive of all patients who were transplanted on study even though only 10 patients died at by 1 year time point. This outcome will be referenced in the donor chimerism outcome. Only 26/36 patients were eligible for this time point as that is all that were alive. (NCT00818961)
Timeframe: 1 year
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 4 |
patients are evaluable for their cause of death at Day 100 (NCT00818961)
Timeframe: Day 100
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 1 |
(NCT00818961)
Timeframe: >100 days post-transplant
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 20 |
patients experiencing acute graft versus host disease post-transplant (NCT00818961)
Timeframe: patients were followed for 2 years
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 15 |
Patients will be evaluated up to 4 years post transplant (NCT00818961)
Timeframe: 4 years
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 0 |
DLI is used for patients with mixed chimerism following transplant (NCT00818961)
Timeframe: Day 100
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 19 |
Evaluation of overall survival at 1 year (# of patients who are alive at 1 year post-transplant) (NCT00818961)
Timeframe: 1 year
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 26 |
The number of patients experiencing platelet engraftment post-transplant (NCT00818961)
Timeframe: Day 100
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 35 |
Survival at Day 100 (NCT00818961)
Timeframe: 100 day
| Intervention | participants (Number) |
|---|---|
| Hematopoietic Stem Cell Transplantation | 35 |
Analysis of the Primary Endpoint: The complete responses will be estimated by the number of patients with CR divided by the total number of evaluable patients. (NCT01723839)
Timeframe: 28 day cycle, up to 4 cycles
| Intervention | Percentage of Participants (Number) |
|---|---|
| FCR With Lenalidomide | 45 |
Analysis of the other Secondary Endpoints: The overall response rate will be estimated by the number of patients with complete and partial responses divided by the total number of evaluable patients. (NCT01723839)
Timeframe: 28 day cycle, up to 6 cycles
| Intervention | Percentage of Participants (Number) |
|---|---|
| FCR With Lenalidomide | 95 |
Here is the number of participants with adverse events. For the detailed list of adverse events see the adverse event module. (NCT00001586)
Timeframe: 13 years, 10.5 months
| Intervention | Participants (Number) |
|---|---|
| Intermediate-high Risk B-Cell Pts | 18 |
Changes in lymphocyte gene expression was measured by deoxyribonucleic acid (DNA) microarray analysis of circulating leukemic cells after completion of study treatment. A change in expression is defined as a >50% increase in circulating leukemic cells or a 30% decrease in circulating leukemic cells. (NCT00001586)
Timeframe: 6 hours post treatment, and 24 hours post treatment
| Intervention | Percent change in cells (Number) | |
|---|---|---|
| 6 hours post treatment (e.g. ># cells) | 24 hours post treatment (e.g. > # cells) | |
| Intermediate-high Risk B-Cell Pts | 30 | 50 |
29 reviews available for prednisone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas.
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bendamustine H | 2021 |
Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Topics: Acneiform Eruptions; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and ove | 2021 |
An update for Richter syndrome - new directions and developments.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2017 |
Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia - an updated meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Chlorambu | 2019 |
Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Humans; Leukemia | 2014 |
[Chronic lymphocytic leukemia].
Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclo | 2014 |
Cutaneous Richter syndrome: a better place to transform?
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2015 |
Richter syndrome: an aggressive transformation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Cyclophosphami | 2015 |
Cutaneous Richter Syndrome mimicking a lower limb cellulitis infection - a case report and review of the literature.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2016 |
Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanize | 2009 |
[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cycl | 2011 |
Cutaneous granulomatous vasculitis associated with chronic lymphocytic leukemia: case report and review of literature of a rare entity.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Bendamustine Hydrochloride; Biopsy; Erythrocy | 2012 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamusti | 2012 |
Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature.
Topics: Aged; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases; | 2002 |
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodie | 2002 |
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Co | 2003 |
The chronic leukemias: current and novel therapeutic approaches.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubici | 2003 |
B-CLL in PLL transformation associated with hypercalcemia.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chlorambucil; Cyclophosph | 1994 |
Interstitial lung disease--an underdiagnosed side effect of chlorambucil?
Topics: Chlorambucil; Humans; Interferon Type I; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases, Inte | 1993 |
Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.
Topics: ABO Blood-Group System; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; | 1993 |
Acute liver failure due to hepatic involvement by hematologic malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lym | 1997 |
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Glucoc | 1999 |
Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Ad | 1999 |
A clinical update on chronic lymphocytic leukemia. II. Critical analysis of current chemotherapeutic modalities.
Topics: 2-Chloroadenosine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transpla | 1992 |
Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Infusions, | 1990 |
[Massive bilateral non-Hodgkin's lymphoma of the adrenal glands].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1990 |
Non Hodgkin's lymphomas following chemoradiotherapy for Hodgkin's disease. Two new cases and a review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Head and | 1986 |
48 trials available for prednisone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclo | 2022 |
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2021 |
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2015 |
[Clinical Efficacy and Safety of Rituximab Combined with Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lym | 2016 |
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2016 |
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2008 |
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyc | 2011 |
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxo | 2012 |
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Disease Progression; Dr | 2003 |
Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female | 2004 |
The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cladribine; Cross-Over Studies; | 2005 |
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosph | 2006 |
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cladribine; Cyclophosphamide; Do | 2005 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cyclophospham | 2007 |
The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Combined Modality Therapy; Cycloph | 2007 |
Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cycl | 2008 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1994 |
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; C | 1995 |
Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1994 |
Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Hu | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; Drug Administration Sche | 1993 |
When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Topics: Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambuc | 1993 |
Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemother | 1996 |
Fludarabine in chronic leukaemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cycloph | 1996 |
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Topics: Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 1996 |
An "all-oral" combination therapy in chronic lymphocytic leukemia including the oral idarubicin.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Id | 1996 |
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. Int
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Case-Contro | 1997 |
Effect of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) on chemotherapy-induced myelosuppression in patients with chronic lymphocytic leukemia: a crossover study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; F | 1997 |
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambuci | 1998 |
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Co | 1998 |
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients.
Topics: 2-Chloroadenosine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; C | 2000 |
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cladri | 2000 |
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxor | 2001 |
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Disease-F | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cy | 2001 |
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymp | 1992 |
Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; | 1992 |
Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia.
Topics: Cyclosporine; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mal | 1992 |
Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Drug Ad | 1991 |
Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1990 |
Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1989 |
CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as Topic; Cyclop | 1988 |
A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as Topic; Cyclop | 1988 |
CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as Topic; | 1988 |
The UK Medical Research Council CLL trials 1 and 2.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as Topic; | 1988 |
172 other studies available for prednisone and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Topics: Aged; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B- | 2023 |
Autoimmune hemolytic anemia, adverse event to venetoclax.
Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2019 |
Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: A Rare Case Report from Nephrology.
Topics: Acute Kidney Injury; Aged, 80 and over; Cough; Diagnosis, Differential; Dyspnea; Female; Humans; Leu | 2019 |
Pyoderma gangrenosum developing after chest tube placement in a patient with chronic lymphocytic leukemia.
Topics: Aged, 80 and over; Chest Tubes; Diagnosis, Differential; Humans; Immunosuppressive Agents; Leukemia, | 2019 |
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Col | 2020 |
Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic Leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorub | 2020 |
Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment.
Topics: Adenine; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation | 2020 |
Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-C | 2020 |
Ulcerated cutaneous Richter syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophospham | 2020 |
Relationship between vasculitis and chronic lymphocytic leukaemia: a correlation without causation.
Topics: Acute Kidney Injury; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, A | 2020 |
Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Huma | 2021 |
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox | 2022 |
Widespread poikilodermatous dermatomyositis associated with chronic lymphocytic leukemia.
Topics: Abdomen; Antineoplastic Agents, Immunological; Arm; Back; Dermatomyositis; Diagnosis, Differential; | 2017 |
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2018 |
Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies.
Topics: Aged; Antibodies; Blood Coagulation Tests; Coagulants; Cyclophosphamide; Echocardiography; Factor VI | 2017 |
Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Combined Chemotherapy Pro | 2018 |
Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aut | 2019 |
Radiation Therapy Induced Esophageal Ulcer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Cyclophosphamide; Glomerulon | 2018 |
Image Gallery: Polymorphic lesions in a haematological patient.
Topics: Aged; Biopsy; Diagnosis, Differential; Eosinophilia; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; | 2019 |
CLL associated giant cell hepatitis.
Topics: Antineoplastic Agents, Hormonal; Hemochromatosis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Li | 2019 |
Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2013 |
Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 2013 |
Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy | 2014 |
Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; An | 2014 |
Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine | 2015 |
Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2015 |
The efficacy of ibrutinib in the treatment of Richter syndrome.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antibodies, Monoclonal, Murine-Derived; Antineop | 2015 |
Organizing pneumonia appearing in B-cell chronic leukemia malignancy progression - a case report.
Topics: Aged; Cryptogenic Organizing Pneumonia; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, | 2015 |
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2015 |
Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Biop | 2015 |
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy | 2016 |
Ibrutinib-induced pyoderma gangrenosum.
Topics: Adenine; Cyclosporine; Drug Therapy, Combination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Ma | 2016 |
Multiple mucosal ulcerations caused by idelalisib.
Topics: Dexamethasone; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; | 2017 |
Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2008 |
Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2008 |
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
Topics: Anti-Infective Agents; Antifungal Agents; Glucocorticoids; Humans; Immunocompromised Host; Leukemia, | 2009 |
Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2009 |
[Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 2009 |
Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
Topics: Aged; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2010 |
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2010 |
Hodgkin's lymphoma variant of Richter's syndrome.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2010 |
Periorbital non-Hodgkin's lymphoma after blunt trauma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Ble | 2010 |
[Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Ag | 2010 |
[Clinicopathologic features of lymphoplasmacytic lymphoma].
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; | 2010 |
[Richter syndrome: report of a case].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic | 2010 |
Richter's transformation of chronic lymphocytic leukemia.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2011 |
Chlorambucil in indolent mantle cell lymphoma--just another old drug for a new disease?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Disease Progressio | 2011 |
Autografting CLL: the game is over!
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyc | 2011 |
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphami | 2013 |
Re-treatment with cladribine-based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclopho | 2002 |
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; | 2002 |
Association of a novel single nucleotide polymorphism, G(-248)A, in the 5'-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance.
Topics: 5' Untranslated Regions; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ba | 2002 |
One-year follow-up of a patient with reversible tricuspid valve stenosis due to lymphomatic mass into the right atrioventricular wall.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Follow-Up Studi | 2002 |
Obstructive sleep apnea secondary to chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Chemical Analysis; Blood Gas Analysis; C | 2002 |
Hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, and chronic lymphocytic leukemia treated with rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclophosph | 2003 |
Richter's syndrome: a novel presentation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; | 2003 |
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Topics: Aged; Autoimmune Diseases; Cohort Studies; Coombs Test; Cyclosporine; Drug Therapy, Combination; Glu | 2003 |
Corticosteroid therapy of chronic lymphocytic leukaemia: a study of erythrocyte survival and leukocyte dynamics.
Topics: Adrenal Cortex Hormones; Erythrocyte Aging; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell | 1960 |
[Corticosteroid therapy of chronic lymphatic leukemia].
Topics: Adrenal Cortex Hormones; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoi | 1963 |
[Prednisone treatment of chronic lymphatic leukemia].
Topics: Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Prednisone | 1962 |
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; | 2003 |
[Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambu | 2003 |
Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineo | 2004 |
45th annual meeting of the American Society of Hematology. December 6-9, 2003, San Diego, California.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2003 |
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2004 |
Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dyspnea; Fatal | 2004 |
Membranous glomerulonephritis in chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Cyclophosphamide; Glome | 2004 |
Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antin | 2004 |
Marrow fibrosis and pure red cell aplasia complicating early stage chronic lymphocytic leukaemia.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Midd | 2005 |
Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2005 |
Enteroviral meningoencephalitis in a patient with non-Hodgkin's lymphoma treated previously with rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2006 |
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Drug Combina | 2006 |
[Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; | 2006 |
Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hepat | 2007 |
[Merkel cell carcinoma in a patient with chronic lymphocytic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cyclophosphamide; Diagnosis, | 2006 |
Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 14; Chromosom | 2006 |
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Muri | 2006 |
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineopla | 2007 |
Malignant uveitis masking a lymphocytic lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2006 |
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Topics: Aged; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2007 |
[Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; DNA, Viral; Epstein-Barr Virus Infections; | 2007 |
[Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cote d'Ivoire; C | 2007 |
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Topics: Agammaglobulinemia; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine- | 2008 |
Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005).
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cat Diseases; Cats; Chl | 2008 |
Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Dyspnea; Fatal Outco | 1995 |
TNF-alpha induces spreading of B-CLL via the CD11c/CD18 molecule.
Topics: Antigens, CD; B-Lymphocytes; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cell Division; Culture Tec | 1993 |
MDR1 gene expression in chronic lymphocytic leukemia.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; AT | 1994 |
Late listeriosis after fludarabine plus prednisone treatment.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans; | 1994 |
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma | 1994 |
[Primary malignant lymphoma of the urinary bladder achieving complete response by COMPA intraarterial chemotherapy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1994 |
Listerial brain abscess in a patient with chronic lymphocytic leukemia treated with fludarabine.
Topics: Aged; Antineoplastic Agents; Brain Abscess; Cefotaxime; Drug Therapy, Combination; Gentamicins; Huma | 1993 |
Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Deamino Arginine Vasopressin; Ecchymosis; Factor VIII; Female; Follow-Up St | 1993 |
Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cyclopho | 1993 |
Combined use of alpha 2B-interferon, chlorambucil, and prednisone in the treatment of previously treated B-chronic lymphocytic leukemia patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Human | 1993 |
Response to cyclosporin A and recombinant human erythropoietin in a case of B cell chronic lymphocytic leukemia and pure red cell aplasia.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Chlorambucil; Cyclosporine; Erythropoietin; Follow-Up St | 1996 |
Case reports: continuous corticosteroids for refractory poorly differentiated lymphocytic lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Female; Humans; Leukemia; Leukemia, Lymphocytic, Chron | 1996 |
Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12 | 1996 |
Chronic lymphocytic leukaemia with upper airway obstruction.
Topics: Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; | 1996 |
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1995 |
Pure red-cell aplasia requiring cytotoxic chemotherapy: presence of clonal T-lymphocytes without characteristics of chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clone Cells; Cyclophosphamide; Cytotoxicity, Immunol | 1996 |
Drug resistance mechanisms in chronic lymphocytic leukemia.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocol | 1996 |
The COP regimen is not a feasible treatment for advanced, refractory chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Feasibility Studies; Female; | 1996 |
[Deep morphea-type lesions, first manifestations of lymphocytic lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemi | 1996 |
[Paraneoplastic pemphigus in chronic lymphocytic leukemia].
Topics: Glucocorticoids; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle | 1996 |
Chronic lymphocytic leukemia in the elderly population.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Ag | 1997 |
[Coexistence of chronic lymphoid leukemia and Hodgkin's disease. Immunohistochemical study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Hodgkin Disease; Humans; Immunop | 1996 |
Steroid-responsive interstitial pneumonitis after fludarabine therapy.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Cough; Fatal Outcome; Glucocorticoids; Humans | 1997 |
Sjögren's syndrome with acute renal failure caused by renal pseudolymphoma.
Topics: Acute Kidney Injury; Glucocorticoids; Humans; Kidney; Kidney Neoplasms; Leukemia, Lymphocytic, Chron | 1996 |
Listeriosis after fludarabine treatment for chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, | 1997 |
[A case of recurrent untreated non-hodgkin's lymphoma localized in the nasopharynx and maxillary sinuses after a 10-year remission].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocyt | 1996 |
Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic | 1997 |
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 1997 |
Prolymphocytic leukemia: diagnosis and treatment. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy, Needle; Bone Marrow; Combined | 1997 |
[Chronic lymphatic leukemia. A population-based study of symptoms, findings, complications and choice of treatment].
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Female; Foll | 1998 |
[Evaluation of the treatment used in a case of autoimmune hemolytic anemia using the erythrophagocytosis functional test].
Topics: Anemia, Hemolytic, Autoimmune; Cells, Cultured; Coombs Test; Danazol; Erythrocytes; Evaluation Studi | 1998 |
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Humans; Infusions, Intravenous; | 1997 |
Reversible renal failure due to specific infiltration of the kidney in chronic lymphocytic leukaemia.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil | 1998 |
DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Antineoplastic Agents, Alkylating; Antineoplastic Comb | 1998 |
Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combine | 1998 |
DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell | 1997 |
Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
Topics: Aged; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Humans; Immunosuppressive Agents; Incidenc | 1998 |
Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fatal Outcome; Humans; Hyper | 1999 |
Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
Topics: Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; | 1999 |
Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamid | 1999 |
2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Topics: Adult; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ch | 1999 |
Blood histamine levels in patients with chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Histamine; Hu | 1999 |
Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Immune Tolerance; Leukemia, Ly | 1999 |
The usefulness of in vivo gene expression investigations from peripheral white blood cells: a preliminary study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Doxorubicin; | 1999 |
Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunocytochemistry.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy | 1999 |
[Chronic lymphatic leukemia and Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Doxorubicin; F | 1999 |
Primary lymphoplasmacytoid lymphoma of the trachea with immunoglobulin G paraprotein.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnosis, Diff | 1999 |
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidi | 2000 |
Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chr | 2000 |
Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercula | 2000 |
Images in haematology: non-Hodgkin's lymphoma of the pelvic bone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophos | 2001 |
[The interesting case No. 43].
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phy | 2001 |
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cells, Cultured; Chlorambucil; | 2001 |
Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2001 |
[Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Biopsy; Chlorambucil; Drug Therapy, Com | 2001 |
[Acquired C1-esterase inhibitor deficiency with angioedema in lymphoplasmocytic lymphoma].
Topics: Aged; Angioedema; Antineoplastic Combined Chemotherapy Protocols; Complement C1 Inactivator Proteins | 2001 |
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorub | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cy | 2001 |
[Non-Hodgkin's lymphoma of the uterus: apropos of 4 cases and review of the literature].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cervix Uteri; Cyclophosphamide; Diagno | 2002 |
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Ce | 2002 |
Primary cerebral lymphoma and membranous nephropathy: a still unreported association.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Female; Glo | 2002 |
Composite mycosis fungoides and B-cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Combined Modality Therapy; | 2002 |
Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Female; Humans; Le | 1992 |
Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubici | 1992 |
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.
Topics: Adult; Aged; Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; Antineoplastic C | 1992 |
Primary malignant lymphoma of the spleen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1992 |
[Severe tetraparesis as the first manifestation of a chronic lymphatic leukemia].
Topics: Aged; Chlorambucil; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leukemia, Ly | 1992 |
Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Interferon alph | 1992 |
[Vincristine-induced recurrent laryngeal nerve paralysis].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1992 |
New chromosomal abnormality. t(1;19;?) in a case of B-chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Chlorambucil; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Fema | 1992 |
Pulmonary complications of combination therapy with cyclophosphamide and prednisone.
Topics: Aged; Bronchiolitis Obliterans; Cyclophosphamide; Drug Therapy, Combination; Female; Granulomatosis | 1991 |
An unusual case of chronic lymphocytic leukemia.
Topics: Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; | 1991 |
[Cyclosporin A in the treatment of acquired erythroblastopenia in the course of B-cell chronic lymphatic leukemia].
Topics: Autoimmune Diseases; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Humans | 1991 |
Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL)
Topics: Aged; Chlorambucil; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B- | 1991 |
[Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Humans; | 1991 |
[Pure red cell aplasia in chronic lymphatic leukemia. Successful treatment using immunosuppression].
Topics: Aged; Antilymphocyte Serum; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; Leukemia, L | 1990 |
Primary renal non-Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; H | 1990 |
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Hepatitis B; Hepatit | 1990 |
The use of 'CHOP' in the treatment of CLL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lym | 1990 |
The lymphocytic basophilia after incubation of blood smears in distilled water.
Topics: Basophils; Chlorambucil; Cytoplasmic Granules; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph | 1988 |
Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.
Topics: Adult; Aged; Azathioprine; B-Lymphocytes; Cyclosporins; Drug Therapy, Combination; Female; Graft Rej | 1989 |
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule | 1989 |
Diffuse well-differentiated lymphocytic lymphoma: chemotherapy with BCNU, cyclophosphamide, vincristine, melphalan and prednisone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; L | 1988 |
Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1988 |
Angioimmunoblastic lymphadenopathy with dysproteinemia in Thailand.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dysgammaglobulinemia; | 1987 |